These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21796524)

  • 21. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
    Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
    J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.
    Lagarde WH; Blackwelder AJ; Minges JT; Hnat AT; French FS; Wilson EM
    J Biol Chem; 2012 Mar; 287(14):10905-15. PubMed ID: 22334658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
    Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
    Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
    Wang Q; Lu J; Yong EL
    J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
    He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
    Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
    Ikonen T; Palvimo JJ; Jänne OA
    J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
    Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
    J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.
    van de Wijngaart DJ; van Royen ME; Hersmus R; Pike AC; Houtsmuller AB; Jenster G; Trapman J; Dubbink HJ
    J Biol Chem; 2006 Jul; 281(28):19407-16. PubMed ID: 16690616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations.
    Jin Y; Duan M; Wang X; Kong X; Zhou W; Sun H; Liu H; Li D; Yu H; Li Y; Hou T
    J Chem Inf Model; 2019 Feb; 59(2):842-857. PubMed ID: 30658039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
    Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
    J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain.
    He B; Kemppainen JA; Voegel JJ; Gronemeyer H; Wilson EM
    J Biol Chem; 1999 Dec; 274(52):37219-25. PubMed ID: 10601285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.
    van de Wijngaart DJ; Dubbink HJ; Molier M; de Vos C; Trapman J; Jenster G
    Mol Endocrinol; 2009 Nov; 23(11):1776-86. PubMed ID: 19762545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).
    He B; Bai S; Hnat AT; Kalman RI; Minges JT; Patterson C; Wilson EM
    J Biol Chem; 2004 Jul; 279(29):30643-53. PubMed ID: 15107424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
    Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
    Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
    Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.